Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.12B |
| 2 |
ExxonMobil
XOM
|
+$884M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$856M |
| 4 |
American International
AIG
|
+$594M |
| 5 |
Crown Castle
CCI
|
+$542M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.44B |
| 2 |
Gilead Sciences
GILD
|
+$1.23B |
| 3 |
DuPont de Nemours
DD
|
+$982M |
| 4 |
General Motors
GM
|
+$683M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$664M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.83% |
| 2 | Technology | 12.2% |
| 3 | Industrials | 11.56% |
| 4 | Communication Services | 11.27% |
| 5 | Consumer Discretionary | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Bristol-Myers Squibb
BMY
$130B
| $161M | 0.06% |
3,025,000
-8,000,000
| -73% | -$408M |
|
227
Myriad Genetics
MYGN
$309M
| $160M | 0.06% |
7,624,885
+1,888,185
| +33% | +$47.8M |
|
228
Norfolk Southern
NSC
$75.3B
| $160M | 0.06% |
1,718,800
-1,311,687
| -43% | -$113M |
|
229
Penske Automotive Group
PAG
$14.3B
| $158M | 0.06% |
3,344,000
| – | – |
|
230
Carnival Corporation Ltd
CCL
$37.9B
| $155M | 0.06% |
+3,854,146
| New | +$136M |
|
231
KBR
KBR
$4.8B
| $154M | 0.06% |
4,840,000
| – | – |
|
|
CJES
232
DELISTED
C&J ENERGY SVCS LTD
CJES
| $152M | 0.06% |
6,581,261
| – | – |
|
233
Itron
ITRI
$4.49B
| $150M | 0.06% |
3,630,314
-606,400
| -14% | -$25.7M |
|
234
D.R. Horton
DHI
$40.8B
| $149M | 0.06% |
6,685,000
-1,400,000
| -17% | -$27M |
|
|
CHK
235
DELISTED
Chesapeake Energy Corporation
CHK
| $147M | 0.05% |
+28,671
| New | +$146M |
|
|
MRSH
236
Marsh
MRSH
$90.1B
| $145M | 0.05% |
3,000,000
| – | – |
|
237
SBA Communications
SBAC
$19.4B
| $141M | 0.05% |
1,565,000
| – | – |
|
238
Newmont
NEM
$124B
| $139M | 0.05% |
6,054,690
-5,861,310
| -49% | -$151M |
|
239
Exelixis
EXEL
$12.5B
| $138M | 0.05% |
22,565,030
+17,330
| +0.1% | +$95.5K |
|
|
TIF
240
DELISTED
Tiffany & Co.
TIF
| $136M | 0.05% |
1,469,265
+1,254,462
| +584% | +$104M |
|
241
ITT
ITT
$19.4B
| $136M | 0.05% |
3,121,921
-1,259,000
| -29% | -$50M |
|
242
Cisco
CSCO
$488B
| $135M | 0.05% |
6,000,000
| – | – |
|
243
Flex
FLEX
$46B
| $134M | 0.05% |
22,949,027
-2,985,750
| -12% | -$18.1M |
|
|
XLNX
244
DELISTED
Xilinx Inc
XLNX
| $133M | 0.05% |
2,897,000
-2,773,800
| -49% | -$125M |
|
245
Carlisle Companies
CSL
$15.2B
| $131M | 0.05% |
1,645,500
+458,620
| +39% | +$33.7M |
|
|
DD
246
DELISTED
Du Pont De Nemours E I
DD
| $130M | 0.05% |
2,106,000
-1,053,000
| -33% | -$60.9M |
|
|
PPL
247
PPL Corp
PPL
$26.7B
| $128M | 0.05% |
4,576,605
| – | – |
|
248
Texas Roadhouse
TXRH
$14.1B
| $128M | 0.05% |
4,587,200
| – | – |
|
249
Landstar System
LSTR
$6.31B
| $126M | 0.05% |
2,191,899
+119,199
| +6% | +$6.67M |
|
|
OPEN
250
DELISTED
OPENTABLE,INC COMMON STOCK
OPEN
| $125M | 0.05% |
1,570,840
+278,051
| +22% | +$21.3M |
|
Similar funds
Capital Research Global Investors's Q4 2013 Portfolio in Review
As of Q4 2013, Capital Research Global Investors held 473 positions worth $270B, up 6.6% from $253B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Capital Research Global Investors withdrew a net $8.14B in Q4 2013, closing 44 positions and reducing 142 holdings. Its most notable exit was FOREST LABORATORIES INC, an estimated $664M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.
Against the trend, Capital Research Global Investors opened a new position in American International worth $608M.
- Capital Research Global Investors's largest Q4 2013 buy was American International: 11,917,900 shares worth $608M.
- Capital Research Global Investors added most to Amgen in Q4 2013, an estimated $1.12B increase.
- Capital Research Global Investors's biggest Q4 2013 reduction was Microsoft, cutting an estimated $2.44B.
- Capital Research Global Investors fully exited FOREST LABORATORIES INC in Q4 2013, selling an estimated $664M.
- Capital Research Global Investors's ten largest holdings make up 25% of its $270B portfolio in Q4 2013.
- Capital Research Global Investors opened 27 new positions and closed 44 in Q4 2013.
- Capital Research Global Investors's portfolio value rose 6.6% quarter-over-quarter to $270B.
Based on Capital Research Global Investors's 13F filing for Q4 2013, filed 14 Feb 2014.